tradingkey.logo
tradingkey.logo
Search

Ovid Therapeutics Inc

OVID
Add to Watchlist
2.495USD
-0.075-2.92%
Close 09-24 16:00(ET)
465.67MMarket Cap
LossP/E TTM
TradingKey Chart
Intraday
1m
30m
1h
D
W
M
D

Today

-2.92%

5 Days

-7.59%

1 Month

-11.52%

6 Months

+3.10%

Year to Date

+53.07%

1 Year

+78.21%

Key Figures

2.540Open
2.750High
251.08KVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
0.14%Turnover Ratio
2.570Prev. Close
2.405Low
621.38KTurnover
LossP/E Static
2.22P/B
0.00%Div Yield TTM
-15.73%ROA
3.10552wk High
0.08Volume Ratio
-26.43MNet Profit
186.64MShares
-0.2169EPS TTM
0.17Beta
-18.77%ROE
1.18052wk Low
13.42%Amplitude
100.00%Gross Margin
465.67MMarket Cap
4.35Reward/Risk
5.40%Risk Rate
More news coming soon, stay tuned...

Ovid Therapeutics Inc's Score

0.07vs previous score
Forecast9.00
Financial Health6.07
Technical3.99
Valuation Dimensions8.64
Institutional Confidence3.00
Risk Assessment4.98

Media Coverage

Coverage Level

Very Low
Very High
Positive

Analyst Rating

Strong Buy
Buy
Hold
Sell
Strong Sell
Strong BuyCurrent Rating
6.000Target Price
+133.46%Upside Space
Current Rating2026-092026-082026-072026-062026-052026-042026-032026-02
Strong Buy55555555
Buy55665554
Hold00000000
Sell00000000
Strong Sell00000000

Ovid Therapeutics Inc Technical Analysis

1m
5m
15m
30m
1h
2h
4h
D
W
M
1m
5m
15m
D

Technical Indicators

Strong sell

Summary

Sell

Moving Average

Strong sell

Financial Indicators

Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.
Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.

Earnings

Next reporting date
--
Reporting Period
2026Q2
Earnings / Forecast
-0.08/-0.12
Revenue / Forecast
733.00K/0.00

Ovid Therapeutics Inc Profile

SectorBiotechnology & Medical Research
Ticker SymbolOVID
Number of employees23
CountryUnited States of America

Ownership

ShareholdersProportion
RA Capital Management, LP5.74%
Takeda Pharmaceutical Co Ltd4.71%
Affinity Asset Advisors LLC3.83%
Vanguard Capital Management, LLC2.82%
Shareholder TypesProportion
Hedge Fund17.65%
Investment Advisor7.10%
Venture Capital6.38%
Corporation5.08%

FAQs

What is the current price of Ovid Therapeutics Inc (OVID)?

The current price of Ovid Therapeutics Inc (OVID) is 2.50.

What is the symbol of Ovid Therapeutics Inc?

The ticker symbol of Ovid Therapeutics Inc is OVID.

What is the 52-week high of Ovid Therapeutics Inc?

The 52-week high of Ovid Therapeutics Inc is 3.10.

What is the 52-week low of Ovid Therapeutics Inc?

The 52-week low of Ovid Therapeutics Inc is 1.18.

What is the market capitalization of Ovid Therapeutics Inc?

The market capitalization of Ovid Therapeutics Inc is 465.67M.

Is Ovid Therapeutics Inc (OVID) currently rated as Buy, Hold, or Sell?

According to analysts, Ovid Therapeutics Inc (OVID) has an overall rating of STRONG BUY, with a price target of 6.00.

What is the Earnings Per Share (EPS TTM) of Ovid Therapeutics Inc (OVID)?

The Earnings Per Share (EPS TTM) of Ovid Therapeutics Inc (OVID) is -0.22.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.